[Objective] To explore the protective effect of selenomethionine (Se-Met) on oxidative stress and intestinal barrier damage in mice infected with porcine deltacoronavirus (PDCoV) and the potential regulatory mechanism. [Methods] Forty female C57 mice were randomly grouped as follows: control, Se-Met (0.3 mg/kg Se), PDCoV, and Se-Met+PDCoV (0.3 mg/kg Se). After being fed with or without Se-Met for 23 days, the mice in the PDCoV group and the Se-Met+PDCoV group were administrated with 300 μL suspension of PDCoV HNZK-02-P5 strain (1×10⁶ TCID₅₀) by gavage, while those in the other two groups were administered with the same volume of Dulbecco’s Modified Eagle Medium (DMEM). All the mice were observed daily for clinical signs, food intake, and body weight changes until day 28. At five days post-inoculation (dpi), intestinal tissues were collected and PDCoV titers were determined. Hematoxylin staining and eosin staining were used to monitor pathological changes in intestinal tissues. Oxidative stress-related indicators such as malondialdehyde (MDA), superoxide dismutase (SOD), and glutathione peroxidase (GSH-PX) were investigated. The level of ROS in the jejunum tissue was measured via a 2′,7′-dichlorofluorescein diacetate (DCFH-DA) probe. Immunofluorescence was used to analyze the changes of small intestinal tight junction proteins (ZO-1 and Occludin). The mRNA levels of inflammatory cytokines (TNF-α, IL-1β, IL-6, and IL-10), intestinal tight junction proteins (ZO-1 and Occludin), and the Nrf2 signaling pathway-associated factors (Nrf2, HO-1, and NQO1) were determined by RT-qPCR. Western blotting was employed to assess the protein levels of factors related to the Nrf2 signaling pathway. [Results] The results of body weight, food intake, pathological examination, and viral RNA titers in different intestinal tissues revealed that Se-Met might increase the body weight, decrease viral titers in intestinal tissues, and attenuate PDCoV-induced structural damage of intestinal villi in PDCoV-infected mice. Se-Met attenuated PDCoV-induced inflammation by lowering the mRNA levels of major inflammatory cytokines, such as IL-1β, IL-6, and TNFα in the jejunum. Se-Met ameliorated PDCoV-induced intestinal mucosal barrier damage by up-regulating the mRNA levels of ZO-1 and Occludin in the jejunum. Se-Met ameliorated PDCoV-induced oxidative stress by decreasing the levels of ROS and MDA and increasing the levels of GSH-PX and SOD in the jejunum. Se-Met inhibited PDCoV-induced oxidative stress by activating the Nrf2 signaling pathway. [Conclusion] Se-Met may attenuate the intestinal injury in mice infected with PDCoV by activating the Nrf2 signaling pathway, which provides a theoretical basis for the prevention and treatment of PDCoV infection.